PTPN2/1 inhibitor program (Merck & Co)

N/A

Report date: 2025/06/11 10:52:57
NME

Base Information

Drug NamePTPN2/1 inhibitor program (Merck & Co)
Drug Alias Namedual protein tyrosine phosphatase nonreceptor type 1/2 inhibitor program (Merck & Co)
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein phosphatase non-receptor type 2 inhibitorsProtein-tyrosine phosphatase 1B inhibitors
TargetsTyrosine-protein phosphatase non-receptor type 2Protein-tyrosine phosphatase 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A